The Miami Entrepreneur

The Wall Street Journal: FDA rejects Eli Lilly’s proposed Alzheimer’s treatment, says more data needed

Read Time:9 Second

The setback could delay a potential commercial introduction of the highly anticipated drug by at least several months, if the Food and Drug Administration eventually decides to approve it.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post MarketWatch First Take: Netflix co-founder Reed Hastings showed Silicon Valley the proper leadership path
Next post Dow Jones Newswires: U.K. consumer confidence unexpectedly deteriorates in January